150 related articles for article (PubMed ID: 5132586)
1. Effects of L-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs.
Minsker DH; Scriabine A; Stokes AL; Stone CA; Torchiana ML
Experientia; 1971 May; 27(5):529-31. PubMed ID: 5132586
[No Abstract] [Full Text] [Related]
2. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
Minsker DH; Stokes AL
Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
[No Abstract] [Full Text] [Related]
3. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
Osborne MW; Wenger JJ; Willems W
J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901
[No Abstract] [Full Text] [Related]
4. Localization of the site of the central sympatho-inhibitory action of 1-Dopa in dogs and cats.
Schmitt H; Fenard S
Eur J Pharmacol; 1973 May; 22(2):212-6. PubMed ID: 4715222
[No Abstract] [Full Text] [Related]
5. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
Henning M; Rubenson A
J Pharm Pharmacol; 1970 Aug; 22(8):553-60. PubMed ID: 4394527
[No Abstract] [Full Text] [Related]
6. Parkinsonian syndromes. Treatment by association of L-dopa plus decarboxylase inhibitor.
Gauthier G; Juge O; Birchler A
Eur Neurol; 1974; 11(3):133-57. PubMed ID: 4839098
[No Abstract] [Full Text] [Related]
7. The effect of various agents on the pressor response to dopa in the anesthetized dog.
Pruss TP; McGill JS
Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043
[No Abstract] [Full Text] [Related]
8. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
Watanabe AM; Parks LC; Kopin IJ
J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
[TBL] [Abstract][Full Text] [Related]
9. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
Butcher L; Engel J; Fuxe K
J Pharm Pharmacol; 1970 Apr; 22(4):313-6. PubMed ID: 4392579
[No Abstract] [Full Text] [Related]
10. Evidence for a centrally mediated hypotensive effect of L-dopa in the rat.
Henning M; Rubenson A
J Pharm Pharmacol; 1970 Mar; 22(3):241-3. PubMed ID: 4399501
[No Abstract] [Full Text] [Related]
11. Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes.
Watanabe AM; Chase TN; Cardon PV
Clin Pharmacol Ther; 1970; 11(5):740-6. PubMed ID: 5455636
[No Abstract] [Full Text] [Related]
12. Modification of the cardiovascular effects of L-dopa in anesthetized dogs by inhibitors of enzymes involved in catecholamine metabolism.
Robson RD
Circ Res; 1971 Jun; 28(6):662-70. PubMed ID: 4325846
[No Abstract] [Full Text] [Related]
13. Carbidopa attenuation of L-DOPA emesis in dogs: evidence for a cerebral site of action outside the blood-brain barrier.
Lotti VJ; Clark C
Eur J Pharmacol; 1974 Mar; 25(3):322-5. PubMed ID: 4827858
[No Abstract] [Full Text] [Related]
14. [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
Gaillard JM; Schaeppi R; Tissot R
Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):423-37. PubMed ID: 5348411
[No Abstract] [Full Text] [Related]
15. Direct evidence for a centrally-mediated hypotensive action of L-dopa in anesthetized dogs.
Kaplan HR; Barker JW; La Sala SA
Eur J Pharmacol; 1972 Feb; 17(2):273-8. PubMed ID: 4402097
[No Abstract] [Full Text] [Related]
16. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
Seiden LS; Martin TW
Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
[No Abstract] [Full Text] [Related]
17. The action of L(-)-dopa on baroreflexes in Parkinsonism.
Reid JL; Calne DB; George CF; Vakil SD
Clin Sci; 1972 Dec; 43(6):851-9. PubMed ID: 4646277
[No Abstract] [Full Text] [Related]
18. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
Strömberg U
Psychopharmacologia; 1970 Aug; 18(1):58-67. PubMed ID: 5535577
[No Abstract] [Full Text] [Related]
19. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
Butcher LL; Engel J
Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
[No Abstract] [Full Text] [Related]
20. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
Bartholini G; Blum JE; Pletscher A
J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
